XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $1.05M invested in XTL Biopharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$2K |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$0 |
| 2 |
2
Morgan Stanley
New York
|
$102K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NC
1
Noked Capital
Tel Aviv,
Israel
| $471K | 198,888 | – | – |
|
|
NI
2
Noked Israel
Ramat Hasharon,
Israel
| $471K | 198,888 | – | – |
|
|
3
Morgan Stanley
New York
| $102K | 49,271 | -1,800 | -4% |
|
|
4
UBS Group
Zurich,
Switzerland
| $2K | 812 | +658 | +427% |
|
|
5
Renaissance Technologies
New York
| – | – | -23,280 | Closed |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| – | – | -153 | Closed |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|